Commission Implementing Regulation (EU) 2018/1796 of 20 November 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorpyrifos, chlorpyrifos-methyl, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, dimoxystrobin, fenoxaprop-p, fenpropidin, lenacil, mancozeb, mecoprop-p, metiram, nicosulfuron, oxamyl, picloram, pyraclostrobin, pyriproxyfen and tritosulfuron
Proposed act with possible EEA relevance
Adopted act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
121/2019 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2018/1796 of 20 November 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorpyrifos, chlorpyrifos-methyl, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, dimoxystrobin, fenoxaprop-p, fenpropidin, lenacil, mancozeb, mecoprop-p, metiram, nicosulfuron, oxamyl, picloram, pyraclostrobin, pyriproxyfen and tritosulfuron
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2018/1796 frá 20. nóvember 2018 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilum fyrir virku efnin amíðsúlfúrón, bífenox, klórpýrifos, klórpýrifosmetýl, klófentesín, díkamba, dífenókónasól, díflúbensúrón, díflúfeníkan, dímoxýstróbín, fenoxapróp-p, fenprópidín, lenasíl, mankóseb, mekópróp-p, metíram, níkósúlfúrón, oxamýl, píklóram, pýraklóstróbín, pýriproxýfen og trítósúlfúrón
Durchführungsverordnung (EU) 2018/1796 der Kommission vom 20. November 2018 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Dauer der Genehmigung für die Wirkstoffe Amidosulfuron, Bifenox, Chlorpyrifos, Chlorpyrifos-methyl, Clofentezin, Dicamba, Difenoconazol, Diflubenzuron, Diflufenican, Dimoxystrobin, Fenoxaprop-P, Fenpropidin, Lenacil, Mancozeb, Mecoprop-P, Metiram, Nicosulfuron, Oxamyl, Picloram, Pyraclostrobin, Pyriproxyfen und Tritosulfuron
History
01.06.2019
Adopted JCD confirmed entry into force date
01.06.2019
Compliance date in the EEA
08.05.2019
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
06.03.2019
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
20.11.2018
Adoption date in the EU
24.11.2018
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.